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Abstract. Aged garlic extract (AGE) has been demonstrated to 
have therapeutic properties in tumors; however its mechanisms 
of action have not yet been fully elucidated. A previous study 
revealed that AGE exerts an anti-proliferative effect on a panel 
of both sensitive [wild-type (WT)] and multidrug-resistant 
(MDR) human cancer cells. Following treatment of the cells 
with AGE, cytofluorimetric analysis revealed the occurrence 
of dose-dependent mitochondrial membrane depolarization 
(MMD). In this study, in order to further clarify the mechanisms 
of action of AGE, the effects of AGE on mitochondria isolated 
from rat liver mitochondria (RLM) were also examined. AGE 
induced an effect on the components of the electrochemical 
gradient (ΔµH+), mitochondrial membrane potential (ΔΨm) and 
mitochondrial electrochemical gradient (ΔpHm). The mito-
chondrial membrane dysfunctions of RLM induced by AGE, 
namely the decrease in both membrane potential and chemical 
gradient were associated with a higher oxidation of both the 
endogenous glutathione and pyridine nucleotide content. To 
confirm the anti-proliferative effects of AGE, experiments 
were performed on the human neuroblastoma (NB) cancer 
cells, SJ‑N‑KP and the MYCN‑amplified IMR5 cells, using its 
derivative S-allyl-L-cysteine (SAC), with the aim of providing 
evidence of the anticancer activity of this compound and its 
possible molecular mechanism as regards the induction of cyto-
toxicity. Following treatment of the cells with SAC at 20 mM, 
cell viability was determined by MTT assay and apoptosis was 
detected by flow cytometry, using Annexin V‑FITC labeling. 
The percentages of cells undergoing apoptosis was found to be 
48.0% in the SJ‑N‑KP and 50.1% in the IMR5 cells. By cytofluo-
rimetric analysis, it was suggested that the target of SAC are the 
mitochondria. Mitochondrial activity was examined by labeling 
the cells with the probe, 5,5',6,6'-tetrachloro-1,1',3,3'-tetraeth-
ylimidacarbocyanine iodide (JC-1). Following treatment with 
SAC at 50 mM, both NB cell lines exhibited a marked increase 
in MMD. On the whole, the findings of this study indicate 
that both natural products, AGE and SAC, cause cytotoxicity 
to tumor cells via the induction of mitochondrial permeability 
transition (MPT).
Introduction
Garlic (Allium sativum L.) is a species of the onion family, 
and has been widely used as a food and also as a folk medi-
cine. A previous study demonstrated that aged garlic extract 
(AGE) exerts an anti-proliferative effect on a panel of both 
sensitive [wild-type (WT)] and multidrug-resistant (MDR) 
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human cancer cells (1). Following treatment of the cells with 
AGE, cytofluorimetric analysis revealed the occurrence of 
dose-dependent mitochondrial membrane depolarization 
(MMD) (1). A large number of epidemiological investigations 
have suggested that garlic is active in the prevention and 
treatment of various diseases with multiple pharmacological 
functions, such as anticarcinogenic (2), antithrombotic (3), 
hypolipidemic (4) and hepatoprotective (5) activities. It has 
been reported that garlic is able to suppress carcinogenesis 
and to inhibit the proliferation of cancer cells (e.g., esopha-
geal, gastric, colorectal, lung, skin and prostate cancer cells) 
in vivo and in vitro (6). These studies have yielded significant 
findings, since the number of cancer patients worldwide has 
recently increased (1). Moreover, garlic has been reported 
to be beneficial in preventing neurodegeneration due to its 
antioxidant and amyloid β (Aβ)-lowering properties (7). 
Among a number of different natural products, such as 
fruits, vegetables, herbs and other compounds, garlic has 
represented one of the most important sources of dietary 
supplements, not only for health advantages, but also for 
medicinal purposes for centuries. Among a large diversity 
of commercially available garlic supplements, AGE is more 
widely known and has been carefully studied. It is prepared 
by immersing fresh garlic in 15% aqueous ethanol solution 
over a prolonged period of time (up to 20 months) at room 
temperature (8). AGE is a commercial odorless preparation 
with antioxidant properties for scavenging reactive oxygen 
species (ROS) (9,10). This natural product has been shown 
to possess immunomodulatory and anticancer properties. 
These effects have been demonstrated by in vitro and in vivo 
experiments; however, its mechanisms of action remain to be 
fully elucidated (11). It was recently demonstrated by an MTT 
assay that AGE induces an anti-proliferative effect on several 
sensitive and MDR human cancer cells (1).
A number of the beneficial effects of garlic have been 
shown to be attributed to various bioactive compounds isolated 
from garlic, including the lipid-soluble allyl sulfur compounds 
(e.g., diallyl sulfide, diallyl disulfide and diallyl trisulfide) and 
water-soluble compounds, such as S-allyl-L-cysteine (SAC) 
and S-allylmercaptocysteine (SAMC) (12-19). Both the organo-
sulfur compounds, SAC and SAMC, are the major bioactive 
components identified in AGE (18). Recent studies have indi-
cated that numerous natural bioactive molecules, including 
organosulfur compounds from Allium vegetables, have been 
reported to have possible preventive and therapeutic properties 
against certain types of cancer (20). SAC is the most abundant 
organosulfur compound in aged-garlic extract (0.62 mg SAC/g 
product) and has been used to standardize the commercial 
products of AGE (12). Several studies have demonstrated that 
SAC exhibits antioxidant properties by scavenging ROS and 
reactive nitrogen species (RNS), regulating oxidation-related 
pathways, as well as neuroprotective properties and anticancer 
activities (21-23). Several other studies have also demonstrated 
that SAC exerts anticancer effects by suppressing the cellular 
proliferation and metastasis, and induces apoptosis in a number 
of cancer models, including ovarian and prostate cancer, and 
hepatocellular carcinoma (20,21,24). Moreover, SAC as a 
natural product with less side-effects, may be considered as 
an excellent candidate for the treatment of neuroinflammatory 
diseases, such as multiple sclerosis, a deleterious autoimmune 
and demyelinating disorder of the central nervous system (CNS) 
with debilitating sensory and motor complications (25-27).
In this study, mitochondrial membrane alterations of 
rat liver mitochondria (RLM) and the oxidation of both 
endogenous glutathione and endogenous pyridine nucleo-
tides following incubation with AGE, were demonstrated. 
Moreover, to further examine the anti-proliferative activity of 
SAC, the in vitro effects of this compound were examined by 
an MTT assay using the human NB cell lines, SJ-N-KP and 
the MYCN‑amplified IMR5 cell line; the cell cycle and apop-
tosis were examined using PI and Annexin V‑FITC labeling 
and flow cytometric assays. By labeling the NB cells with 
the probe, 5,5',6,6'-tetrachloro-1,1',3,3'-tetraethylimidacarbo-
cyanine iodide (JC‑1), cytofluorimetric analysis revealed that 
the target of SAC is the mitochondria, the key bioenergetic 
intracellular organelles, that contain a high large number of 
proteins macromolecules having pivotal functions.
Materials and methods
Reagents. Thiazolyl blue Tetrazolium bromide (MTT), 
verapamil, fetal bovine serum (FBS), 5,5'-dimethyl-oxazoli-
dine-2,4-dione (DMO), cyclosporin A (CsA), nicotinamide 
adenine dinucleotide reduced form (NADH), nicotinamide 
adenine dinucleotide phosphate reduced form (NADPH), 
5,5',6,6'-tetrachloro-1,1',3,3'-tetraethyl-imidacarbocyanine 
iodide (JC-1), 3,4-dimethoxybenzoic acid, hydrochloric acid, 
acetonitrile and sodium bicarbonate were purchased from 
Sigma‑Aldrich. All cell culture flasks and dishes were obtained 
from Corning, Inc. AGE and SAC provided by Wakunaga 
Pharmaceutical Co. Ltd. (Hiroshima, Japan) were manufactured 
as follows: Garlic cloves were sliced, immersed in a water-ethanol 
mixture solution and naturally extracted for >10 months at room 
temperature, as previously described (28). The AGE powder used 
in our experiments was prepared by lyophilization. It contained 
approximately 28.6% (w/v, 286 mg/ml) solid material, 0.63% 
(6.3 mg/ml) arginine and 0.1% SAC (calculated on a dry weight 
basis) as a marker compound for standardization (29). Both 
SAC and the AGE powder was freshly dissolved in complete 
Ham's F-12 or in RPMI-1640 medium prior to each experiment. 
The analysis of the organosulfur compound content in the AGE 
powder was performed using a Shimadzu LC-6A HPLC system. 
The content of SAC was determined by ion-exchange chroma-
tography, using a column TSK-GEL Amino Pak, followed by 
post-derivatization using o-phthalaldehyde (OPA), and a fluores-
cent detection with excitation at 340 nm and emission at 455 nm. 
The test samples for the analysis of SAC were prepared by the 
addition of 5% trichloroacetic acid, as previously described (30). 
The SAC powder was freshly dissolved in RPMI-1640 medium 
supplemented with 10% FBS, normally up to 50 mg/ml, prior 
to each experiment. During the experiment the solution, which 
was kept in the dark, was for one use only.
Cells and cell culture. Two types of NB cells were used in 
this study. One was the SJ‑N‑KP cells, a non‑amplified NB 
cell line and the second one was the IMR5 cells, a n-myc 
amplified NB cell line (31). Both cell lines were a kind gift 
from Dr N. Crescenzio (Department of Paediatrics, University 
of Turin, Regina Margherita Children's Hospital, Turin, 
Italy) and Dr F. Timeus (Paediatric Haematology-Oncology, 
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Regina Margherita Children's Hospital) (31). The NB cell 
lines, SJ-N-KP and IMR5 were maintained in monolayer 
cultures in RPMI-1640 medium supplemented with 10% FBS, 
2 mM L-glutamine, 100 µg/ml streptomycin and 100 IU/ml 
penicillin (31). Both cell lines were incubated in a humidified 
atmosphere of 5% CO2 in a water‑jacketed incubator at 37˚C. 
For each passage, exponentially growing SJ-N-KP and IMR5 
cells were harvested with 10 mM EDTA and by the further 
addition of 0.10% trypsin solution. The trypsin activity was 
quenched by the addition of complete RPMI-1640 medium (31).
Determination of apoptotic cell death by Annexin V‑FITC 
staining. To detect phosphatidylserine residue exposure on the 
surface of the plasma membrane of the tumor cells in the initial 
step of apoptosis, an Annexin V‑FITC apoptosis detection kit 
was used as previously described by Van Engeland et al (32). 
The NB cell lines, SJ-N-KP and IMR5 (9.1x104 cells/ml), were 
seeded in a 6-well plate, containing complete RPMI-1640 
medium and incubated for 24 h at 37˚C to allow for the 
the complete reattachment of the cells to the plates. After 
exchanging the medium with fresh medium, the cells were 
incubated at 37˚C in the presence of 0, 10 and 20 mM SAC for 
48 h. Following incubation at 37˚C, the cells were detached, 
washed with PBS, centrifuged at 400 x g for 2 min at 25˚C 
and then stained with 1 µg/ml of Annexin V‑FITC and with 
1 µg/ml of PI for 10 min at room temperature in the dark. 
Annexin V‑FITC and PI fluorescence were measured on the 
FL-1 channel (533/30 nm) and the FL-3 channel (>670 nm), 
respectively, with excitation at 488 nm. A minimum of 
10,000 events/sample was acquired (32).
Cell cycle analysis. Cell cycle distribution was analyzed by 
labeling the cells with PI. The assays were carried out as previ-
ously described by Nicoletti et al (33). S-allyl-L-cysteine-treated 
and the untreated NB cell lines, SJ-N-KP and IMR5 
(9.1x104 cells/ml), as described above in Annexin V‑FITC 
labeling, were harvested, washed twice with cold PBS and 
centrifuged at 400 x g for 2 min at 4˚C. The pellet was fixed in 
70% ethanol at ‑20˚C for 1 h. After washing twice with PBS, the 
cells were resuspended in PBS containing 100 µg/ml RNase A 
and 40 µg/ml PI. Following incubation at 37˚C for 1 h, the cells 
were subsequently analyzed by flow cytometry using the FL‑3 
channel (>670 nm) with the acquisition of 10,000 events/sample.
SAC dose response assay. The NB cell lines, SJ-N-KP and 
IMR5, were seeded in a 96-well plate and incubated for 24 h to 
allow for the complete reattachment of the cells to the plates. 
After the medium was replaced with fresh medium, the cells 
were incubated in the presence of 0, 1, 5, 10, 20 and 30 mM 
SAC for 48 h. The anti-proliferative effects of SAC on the 
human NB cells were examined by MTT assay. Briefly, MTT 
was added to each well at a final concentration of 0.5 mg/ml. 
Following 3 h of incubation at 37˚C, dimethyl sulfoxide was 
added to dissolve the crystals. The absorbance was determined 
at 577 and 660 nm using a spectrophotometer multi-mode 
plate reader [Synergy HT BioTek, serial no. 270204; BioTek, 
Bernareggio (MB)].
Measurements ‘in situ’ of mitochondrial membrane potential 
(Δψm). The changes in Δψm in whole cells were assayed using 
the lipophilic cationic probe, JC-1 dye. The NB cell lines, 
SJ-N-KP and IMR5, were seeded in a 12-well plate and incu-
bated for 24 h at 37˚C to allow the cells to adhere to the plates. 
After the medium was replaced with fresh medium, the cells 
were incubated with 30 and 50 mM of SAC for 24 h at 37˚C. 
Subsequently, the cells were stained with 2.5 µg/ml of JC-1 
for 20 min at 37˚C. The detached cells were washed with PBS 
and then resuspended in PBS. The samples were then analyzed 
using a BD Accuri C6 flow cytometer (BD Biosciences). JC‑1 
was excited using an argon laser at a wavelength of 488 nm 
(using a BD Accuri C6 flow cytometer). The emitted green 
(JC‑1 monomer) and red (JC‑1 aggregate) fluorescence were 
detected at the FL-1 channel (533/30 nm) and FL-2 channel 
(585/40 nm), respectively. At least 10,000 events/sample were 
acquired in log mode. The ratio of red (FL2)/green (FL1) 
fluorescence intensity was used to represent the Δψm.
Gas chromatography‑mass spectrometry (GC‑MS) 
analysis of AGE and SAC. SAC was analyzed by 
GC-MS as its tert-butyldimethylsilyl (TBDMS) deriva-
tive according to Jiménez-Martín et al (34). Briefly, a 
20 µl aliquot of a solution containing SAC at 1 mg/ml in 
0.1 N HCl spiked with 15 µl internal standard (3,4-dime-
thoxybenzoic acid, 0.1 mg/ml) was dried, and 50 µl of 
neat N-tert-butyldimethylsilyl-N-methyltrifluoroacetamide 
(MTBSTFA), followed by 50 µl of acetonitrile, were added. 
The mixture was heated at 100˚C for 2 h. The sample was then 
neutralized with sodium bicarbonate and subjected to GC-MS 
analysis. The same derivatization protocol was used for AGE 
power (1 mg/0.1 M HCl). GC-MS analyses were performed 
with an Agilent 7890B gas chromatograph coupled to a 5977B 
quadrupole mass selective detector (Agilent Technologies). 
Chromatographic separations were carried out with an Agilent 
HP5 ms fused-silica capillary column (30 m x 0.25 mm i.d.) 
coated with 5%‑phenyl‑95%‑dimethylpolysiloxane (film thick-
ness, 0.25 µm) as a stationary phase. The injection mode was 
splitless at a temperature of 280˚C, the column temperature 
program was 70˚C (1 min) then to 300˚C at a rate of 20˚C/min 
and held for 10 min. The carrier gas was helium at a constant 
flow of 1.0 ml/min. The spectra were obtained in the electron 
impact mode at 70 eV ionization energy; ion source 280˚C; ion 
source vacuum 10-5 Torr. MS analysis was performed simulta-
neously in TIC (mass range scan from m/z 50 to 600 at a rate 
of 0.42 scans/sec) and SIM mode. GC-SIM-MS analysis was 
performed selecting the following ions: m/z 302 and m/z 332 
for SAC and m/z 239 for 3,4-dimethoxybenzoic acid (internal 
standard).
Animals. A total of 50 male Wistar rats, 2 months old, 
weighing approximately 150 g, were used in our experiments. 
The rats, housed in the animal facility of the Department of 
Biomedical Sciences, University of Padova, were maintained 
under controlled conditions (temperature 20‑22˚C, relative 
humidity 48-50%, water with antibacterial control and a 12:12 h 
light/dark cycle) and provided with water and a standard diet 
(4RF25) purchased by Mucedola s.r.l., Settimo Milanese (MI) 
according to Ohkubo et al (1). The experimental procedures 
were approved by the local Ethics Committee for Animal 
Experimentation (CEASA) (protocol no. 3619, 15.1.2014) and 
performed in agreement with the international guidelines, 
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as well as European Communities Council Directive and 
National Regulations (CEE Council 86/609 and DL 116/92).
RLM isolation and purification. Rat liver mitochondria 
(RLM) were isolated by the differential centrifugation 
method according to Ohkubo et al (1). In detail, the rats were 
starved overnight and sacrificed by cervical dislocation. The 
livers were rapidly explanted, immersed in ice-cold isolation 
medium containing 250 mM sucrose, 5 mM HEPES (pH 7.4), 
0.5 mM EGTA and washed 4/5 times with the same medium. 
The livers were minced into small sections and washed with 
ice-cold fresh medium without EGTA. The suspension was 
transferred to a glass potter and homogenized using a Teflon 
pestle operating at 1,600 rpm, by 3-4 strokes. The homogenate 
was centrifuged at 700 x g for 5 min at 4˚C and the obtained 
supernatant was centrifuged at 10,800 x g for 10 min at 4˚C. 
The pellet was washed with isolation medium, resuspended 
and centrifuged at 15,900 x g for 10 min at 4˚C. Finally, the 
obtained pellet, containing the mitochondria, was suspended 
in the standard medium (see the incubation procedure) (35). 
Mitochondrial proteins were measured by the biuret method 
with BSA, as a standard (36). The mitochondria (1 mg 
protein/ml) were incubated in a water‑jacketed cell at 25˚C 
under continuous stirring. The standard medium contained 
250 mM sucrose, 10 mM HEPES (pH 7.4), 5 mM Na-succinate, 
1.25 µm rotenone and 1 mM Na‑phosphate. Variations and/or 
other additions are provided with each experiment.
Determination of mitochondrial functions. Mitochondrial 
membrane potential (ΔΨm) was calculated by detecting the 
distribution of the lipid-soluble cation tetraphenylphospho-
nium (TPP+, Sigma-Aldrich) through the inner membrane, 
measured by a TPP+ selective electrode, according to 
Kamo et al (37). The mitochondrial electrochemical gradient 
(58ΔpHm) was calculated from the distribution of DMO 
([14C]5,5'-dimethyl-oxazolidine-2,4-dione) across the mitochon-
drial membrane, according to Rottemberg (38). 58 is the value 
in mV of RT/zF for giving the ΔpH value in mV. The redox state 
of mitochondrial glutathione was detected by using the Ellman 
reagent, according to Tietze (39). The change with time of the 
redox state of mitochondrial pyridine nucleotides was followed 
fluorometrically in an Aminco Bowman 4‑8202 spectrofluometer 
with excitation at 354 nm and emission at 462 nm.
Statistical analysis. The data were presented as the 
means ± SEM or means ± SD. Statistical analysis was performed 
using one‑way ANOVA with the Dunnett's post hoc test, in EZR 
(Kanda) (40). A P-value <0.05 was considered to indicate a 
statistically significant difference.
Results
Mitochondrial membrane alterations of RLM following 
incubation with AGE. Fig. 1 shows the effects of AGE on the 
components of the electrochemical gradient (ΔµH+), membrane 
potential, ΔΨm, and the chemical gradient, ΔpHm, expressed in 
mV. The results revealed that under normal conditions, both the 
ΔΨm and 58ΔpHm exhibited the physiological values of 170 and 
40 mV, respectively. The presence of AGE induced an initial 
increase in ΔΨm of approximately 30 mV and a corresponding 
identical decrease in 58ΔpHm. However, after approximately 
15 min, the ΔΨm gradually decreased until 120 mV. In addition, 
the 58ΔpHm value underwent a parallel drop of approximately 
10 mV. The membrane alterations of RLM by AGE are shown 
in Fig. 1. The decrease in both ΔΨm and 58ΔpHm was accompa-
nied by an increase in the oxidation of endogenous glutathione 
content. This is evidenced by the decrease in the reduced content 
of glutathione induced by different concentration of AGE as 
reported in Fig. 2. AGE also caused the oxidation of endogenous 
pyridine nucleotides, NADH and NADPH, as observed by the 
downward deflection of the curves detecting the reduced state of 
these nucleotides in Fig. 3. It is also to evidence that cyclosporine 
A (CsA) strongly inhibits the oxidation of both demetabolites.
GC‑MS analysis of AGE and SAC. In this study, we evaluated 
the use of the silylation reagent, MTBSTFA, for the derivatiza-
tion of SAC. MTBSTFA derivatives are more stable and less 
moisture-sensitive than those formed using lower molecular 
weight reagents. A chromatogram of SAC is presented in 
Fig. 4. In the chromatographic condition described above, SAC 
has a retention time of 9,8 min and an electron impact mass 
spectrum (Fig. 4, inset) showing a typical fragment (m/z 302) 
corresponding to the molecular weight of the derivative less 
C3H5S (M-73). In Fig. 5, a typical GC-MS chromatogram of 
AGE is presented. The chromatogram shows the presence of a 
peak having the same retention time and mass spectrum of 
SAC. In addition, TBDMS derivatization allows for the iden-
tification of in AGE a number of polar compounds, including 
amino acids and carboxylic acids. Amino acid derivatives 
were identified by comparing spectral data with those 
reported in the NIST2018 library. Electron impact spectra of 
these derivatives contain typical fragments corresponding to 
the molecular weight of the derivative less CH3 (M-15), C4H9 
(M-57), C4H9 + CO (M-85) and CO-O-TBDMS (M-159).
Anti‑proliferative effects of SAC on the human NB cell lines, 
SJ‑N‑KP and IMR‑5. The results of MTT assays revealed 
Figure 1. Effect of AGE on the components of the ΔµH+, ΔΨm and ΔpHm. 
RLM were incubated in standard medium as described in the Materials and 
methods section supplemented with 2 µM TPP+ for detecting ΔΨm and with 
400 µM [14C]DMO (1 µCi/mmol) plus 5 mM [3H]glycerol (100 µCi/mmol) 
for detecting 58ΔpHm. Where indicated, 2 mg/ml AGE was present. Both 
measurements of ΔΨm and ΔpHm were performed on the same sample. 
A representative experiment is shown. Five other experiments yielded 
almost identical results. AGE, aged garlic extract; ΔµH+, electrochemical 
gradient;  ΔΨm, mitochondrial membrane potential; ΔpHm, mitochondrial 
electrochemical gradient.
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that treatment with SAC exerted anti-proliferative effects 
on the NB cancer cells examined in a dose-dependent manner. 
Treatment with 20 mM of SAC for 48 h decreased the viability 
of both the SJ-N-KP and IMR-5 cells to 30.05 and 33.58%, 
respectively, when compared with the untreated control cells 
(Fig. 6). The proliferation of both cell lines was already mark-
edly decreased to approximately 63.77% of the control level 
following treatment with 5 mM SAC for the same incubation 
time of 48 h (Fig. 6). A further extension of the incubation time 
at 72 h, did not considerably affect the viability of the cells 
(data not shown). A concentration of <5 mM SAC exerted a 
modest effect of about 10% only on the IMR-5 cells.
Analysis of the induction of apoptosis by flow cytometry. 
The loss of phospholipid asymmetry and the appearance of 
phosphatidylserine residues on the outer layer of the plasma 
membrane is an early signal of cell death, namely apoptosis. 
Annexin V is a Ca2+-dependent phospholipid-binding protein 
with a high affinity for phosphatidylserine. In this study, to 
detect externalized phosphatidylserine, Annexin V‑FITC/PI 
staining was performed in the NB cell lines, SJ-N-KP and 
IMR5. The results of flow cytometric analysis are presented 
in Fig. 7. Treatment with 10 and 20 mM of SAC increased the 
percentage of the total apoptotic cells (Fig. 7A, middle and 
upper right panels) to 18.1 and 42.6%, respectively, compared 
with the untreated SJ-N-KP cells (5.2%) (Fig. 7A, upper left 
panel). On the contrary, the percentage of apoptotic cells was 
higher in the IMR5 cells than the SJ-N-KP cells following 
treatment with 10 and 20 mM of SAC (Fig. 7A, lower panels, 
33.0 and 51.7%, respectively, and Fig. 7B), compared with the 
untreated IMR5 cells (6.2%) (Fig. 7A, lower left panel).
To confirm the involvement of apoptotic cell death 
induced by SAC, flow cytometric analysis using PI staining 
was performed to analyze the cell cycle status. The apop-
totic cells that undergo DNA fragmentation exhibit sub-G1 
DNA contents. The exposure of the NB cell lines, SJ-N-KP 
and IMR5, to 10 and 20 mM of SAC for 48 h induced a 
significant increase in the sub‑G1 apoptotic cell population, 
compared to that observed in the untreated control cells 
(Fig. 8). The percentage of treated IMR5 cells in the sub-G1 
phase (38.9 and 67,7%) was higher than the percentage of 
SJ-N-KP cells in the same phase (24.0 and 44.8%), at both 
concentrations of SAC, which was consistent with the results 
of the Annexin V‑FITC/PI staining assay (Fig. 7). These 
results confirm the cytotoxicity induced by both concentra-
tions (10 and 20 mM) of SAC and suggest the involvement 
of an apoptotic mechanism.
Depolarization of Δψm induced by SAC in the NB SJ‑N‑KP 
and IMR5 cell lines. To investigate the mechanisms through 
which SAC induces cell death, we examined the loss of Δψm 
using a flow cytometric analysis of the control and treated 
cells loaded with the mitochondrial probe, JC-1. In healthy 
cells, membrane-permeable JC-1 dye spontaneously accu-
mulates in the mitochondria and forms aggregates known as 
J‑aggregates that emit red fluorescence after excitation. By 
contrast, in apoptotic cells, with a low Δψm, JC-1 remains in 
the cytoplasm as monomers, which emit green fluorescence. 
Figure 3. Changes in the redox state of mitochondrial pyridine nucleotides in 
the presence of AGE. RLM were incubated for 30 min in standard medium 
as described in the Materials and methods section. AGE concentrations 
are indicated in the figure. When present, 1 µM CsA. A typical experiment 
is reported, 4 others yielded identical results. AGE, aged garlic extract; 
RLM, rat liver mitochondria.
Figure 2. Redox state of mitochondrial glutathione in the presence of AGE. 
RLM were incubated for 30 min in standard medium as described in the 
Materials and methods section. AGE concentrations are indicated in the 
figure. When present, 1 µM CsA. Results are the mean values ± SD of 5 
experiments. Data were analyzed by one‑way ANOVA, followed by Dunnett's 
post hoc test. Statistically significant differences (*P<0.05) are indicated by 
asterisks. AGE, aged garlic extract; RLM, rat liver mitochondria.
Figure 4. GC-MS chromatogram of SAC. SAC and internal standard 
were analyzed as TBDMS-derivatives. The inset presents the electron 
impact mass spectrum of SAC bearing two TBDMS-groups. GC-MS, gas 
chromatography-mass spectrometry; SAC, S-allyl-L-cysteine; TBDMS, 
tert-butyldimethylsilyl.
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Therefore, the loss of Δψm is indicated by a decrease in 
the ratio of red/green fluorescence intensity. As shown in 
Fig. 9, in both the NB cell lines SJ-N-KP and IMR5, expo-
sure to SAC induced an evident MMD. Treatment with SAC 
increased the ratio green/red fluorescence intensity and 
concomitantly decreased the red fluorescence intensity in a 
dose-dependent manner. The SAC-induced Δψm dissipation 
was more evident in the IMR5 cells than the SJ-N-KP cells 
following treatment with 50 mM SAC solutions for 48 h at 
37˚C (average 46.6 and 59.1%, respectively). Moreover, a 
decrease in MMD was already observed in the IMR5 cells 
at lower concentrations of SAC, 30 mM, whereas the same 
concentration of SAC did not induce any variations in the 
SJ-N-KP cells, as shown in Fig. 9.
Discussion
Therapeutic approaches based on isolated compounds obtained 
from natural products to handle central and peripheral disor-
ders involving oxidative stress and inflammation are more 
common nowadays. Among the natural compound, garlic, a 
species of the Allium genus, has been used throughout recorded 
history for both culinary and medicinal purposes (20,21,24). 
In our previous study, as well as in numerous other reports, 
it was observed that AGE induced a decrease in the viability 
of several human cancer cell lines (1,20,24,41). This result 
represents an interesting finding, since in conventional cancer 
chemotherapy, numerous issues hamper successful treatment. 
Therefore, the development of more effective and less toxic 
Figure 6. (A and B) Anti-proliferative effects of SAC on human neuroblastoma cell lines. (A) SJ-N-KP and (B) IMR5 cells were treated with 0, 1, 5, 10, 20 and 
30 mM of SAC alone for 48 h. The effects were determined by MTT assay. Each point represents the mean ± SEM of 2 independent experiments, with 3 wells 
per experiment. Where not shown, error bars lie within symbols. Data represent the means ± SD. SAC, S-allyl-L-cysteine.
Figure 5. GC-MS chromatogram of AGE. GC-MS, gas chromatography-mass spectrometry; AGE, aged garlic extract.
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therapeutic regimens is vital for the improvement of survival 
of patients with cancer. Our previous study revealed that the 
treatment of a gastric adenocarcinoma cell line (AGS), a 
human cervical adenocarcinoma cell line (HeLa), a melanoma 
cell line (M14), a human colon adenocarcinoma cell line (LoVo 
WT) and its MDR variant (LoVo DX) cells with AGE was 
accompanied by characteristic mitochondrial alterations, intra-
cellular organelles that represent the bioenergetic key (1). The 
mitochondrial probe JC-1 dye exposure on the outer surface 
of the mitochondrial membrane, clearly revealed the onset 
of the MMD process. In general, the mitochondrial dysfun-
tions of the above-mentioned WT cell lines and the resistant 
phenotype mirrored the results of the cell survival experi-
ments. In addition, it was observed that AGE acts in the RLM 
as a K+/H+ antiporter that directly affects some mitochondrial 
bioenergetic functions. In fact, the prolonged incubation of the 
RLM with AGE induced depolarization and matrix swelling, 
typical alterations of mitochondrial permeability transition 
phenomenon (1). Further new findings reported in this study, 
demonstrated that AGE, during the first 15 min of incubation, 
Figure 7. Annexin V/PI assay: Effect of SAC on SJ‑N‑KP and IMR5 cells. Flow cytometric analysis of apoptosis of neuroblastoma cells following double 
labeling with Annexin V‑FITC and PI. Neuroblastoma cells were treated with increasing concentrations (0, 10 and 20 mM) of SAC. At 48 h after the end of 
the treatment, and incubation at 37˚C, cells were analyzed by flow cytometry. (A) Representative Annexin V‑FITC and PI flow cytometry dot plots of SJ‑N‑KP 
and IMR5 cells are shown. The x‑axis represents FITC staining, and the y‑axis represents PI staining. The percentage of cells displaying Annexin V‑FITC 
positive/PI‑negative (early apoptosis), Annexin V‑FITC positive/PI‑positive (late apoptotic or dead), Annexin V‑FITC negative/PI‑positive (necrotic) and 
double nega tive cells (viable cells) is indicated. The dot plots profile of cells were obtained from 1 out of 2 independent experiments, performed in the same 
experimental conditions, which yielded similar results. (B) Each bar represents the mean ± SD of normal or total apoptotic cells of 2 independent experiments. 
Data were analyzed by one‑way ANOVA, followed by a Dunnett's post hoc test. (A) *P<0.05 vs. control SJ-N-KP cells; and (B) *P<0.05 and ***P<0.001 vs. 
control IMR5 cells. SAC, S-allyl-L-cysteine.
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functioned as a typical activator of the K+/H+ exchanger, as 
mentioned above. This was demonstrated by the increase in 
ΔΨm induced by AGE, that exhibited a similar effect of the 
typical K+/H+ ionophores, nigericin and salinomycin as previ-
ously demonstrated (1). The decrease in ΔΨm and 58ΔpHm 
triggered after 15 min of incubation, was accompanied by the 
oxidation of both endogenous glutathione and endogenous 
pyridine nucleotides (Figs. 2 and 3). The oxidation process 
can be explained as reported in our previous study (1). These 
results demonstrate that the collapse in the ΔµH+ is indicative 
of a general oxidative stress induced by AGE, leading to the 
phenomenon of mitochondrial permeability transition and 
potentially triggering of apoptotic pathway in the cell. The 
induction of MPT is strongly supported by the prevention of the 
oxidation of both glutathione and pyridine nucleotides exhib-
ited by CsA, well known typical inhibitor of MPT. Moreover, 
these data indicate that AGE is able to cause oxidative stress 
in the absence of endogenous Ca2+, following 15 min of incu-
bation, as suggested in our previous study (1). The observed 
oxidation of glutathione and pyridine nucleotides demonstrate 
Figure 8. Cell cycle assay: Effect of SAC on SJ‑N‑KP and IMR5 cells. Cell cycle analysis carried out by flow cytometry on neuroblastoma cells. SJ‑N‑KP and 
IMR5 cells were treated with increasing concentrations (0, 10 and 20 mM) of SAC. At 48 h after the end of the treatment, and incubation at 37˚C, followed 
by the staining with PI and RNase, the cells were analyzed by flow cytometry. (A) Representative histograms of sub‑G1 analysis performed on SJ‑N‑KP 
and IMR5 cells using PI staining are shown. The percentage of the sub-G1 cell population is indicated. The histograms have been obtained from 1 out of 2 
experiments carried out in the same experimental condi tions, which gave similar results. (B) Each bar represents the mean ± SD of sub-G1 cell population 
of 2 independent experiments. Data were analyzed by one‑way ANOVA, followed by Dunnett's post hoc test. ***P<0.001 vs. control SJ-N-KP or IMR5 cells. 
SAC, S-allyl-L-cysteine.
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the involvement of a coupled redox cycling between the above 
compounds that is essential for mitochondrial physiology.
To support the anti-proliferative effects of AGE, experi-
ments were performed on NB cancer cells, the most common 
cancer observed in infancy and the most frequent cause 
of death from extracranial malignant solid tumors in chil-
dren (42). NB originates from the sympathoadrenal lineage 
of neural crest and accounts for 15% of childhood cancer 
mortality. The amplification of the oncogene, N-Myc, is a 
well-established poor prognostic marker for NB. The N-Myc 
amplification status is strongly associated with a higher tumor 
aggression and resistance to treatment. Therefore, besides the 
current treatments that include chemotherapy, surgery and 
radiation, new therapies for patients with N‑Myc‑amplified 
NB need to be developed (43,44). In this study, two NB cell 
lines, SJ-N-KP and MYCN-amplified IMR5, were treated 
with an AGE constituent, SAC, with the aim to demonstrate 
the anticancer activity of this compound and to elucidate the 
possible underlying molecular mechanisms (Figs. 4 and 5, 
GC-MS chromatograms). During the aging of garlic (up to 
20 months), the hydrolysis of the γ-glutamyl-S-allylcysteine 
by γ-glutamyltransferase to form SAC, the major organosulfur 
compound of AGE occurs (45). SAC, an antioxidant with 
neuroprotective properties, is a water-soluble and non-toxic 
compound (46), and is stable since it remains relatively unal-
tered in AGE for up to 2 years (45). The antioxidant properties 
of SAC have been attributed to its capacity to (reviewed in 
ref. 47) i) scavenge ROS/RNS due to the allyl group in its 
structure (48), thus protecting cells against lipid peroxida-
tion, protein oxidation and nitration as well as mitochondrial 
damage; ii) chelate metal ions implicated in ROS/RNS forma-
tion, such as Fe2+ and Cu2+ (49); iii) increase non-enzymatic 
antioxidant defense, such as reduced glutathione (50); 
iv) inhibit pro-oxidant enzymes, such as NADPH oxidase and 
nitric oxide synthase (51); v) inhibit the NF-κB inflamma-
tory pathway (52,53); and vi) contribute to anti‑inflammatory 
responses by increasing NO in endothelial cells (51).
In this study, the effects of cell growth inhibition induced by 
SAC on NB cells were investigated. Since the efficacy of thera-
peutic agents depends on its long-term effect on cancer cells, we 
examined the effects of the treatments on in vitro tumorigenic 
capacity by employing MTT assay, which is widely considered 
to be a valid method for the evaluation of tumor cell sensitivity to 
anticancer drugs. Following treatment of the NB cells, SJ-N-KP 
and MYCN‑amplified IMR5 cells, with SAC at 20 mM at 37˚C 
for 48 h, cell proliferation was detected by MTT assay. The cell 
survival assay revealed that SAC exerted an anti-proliferative 
effect on both NB human cancer cells (Fig. 6).
Apoptosis was evaluated by flow cytometry, in the same 
experimental condition, using Annexin V‑FITC labeling and 
DNA staining with propidium iodide. The results revealed 
that treatment with SAC increased the percentage of apoptotic 
cells in a SAC dose-dependent manner. The percentages of 
Annexin V‑positive cells were 48.0% in the SJ‑N‑KP and 
50.1% in the IMR5 cells (Fig. 7), indicating that treatment with 
SAC was able to induce cell death through apoptosis. Cell cycle 
analysis revealed that the percentages of Annexin V‑positive 
cells were in accordance with those of cells showing a 
hypodiploid sub-G1 peak (Fig. 8). It is known that the mito-
chondria play a pivotal role in the intrinsic apoptotic pathway 
and a reduction in Δψm is an early irreversible step (54). By 
labeling the NB cells with the probe JC‑1 dye, cytofluorimetric 
analysis revealed that the target of SAC was the mitochondria. 
SAC-induced apoptosis was preceded by the Δψm dissipation 
in both the IMR5 and SJ-N-KP cells, following treatment with 
30 and 50 mM SAC (Fig. 9). In view of these results, the use 
of AGE and SAC in cancer therapy deserves to be taken into 
consideration. The findings indicate that both AGE and SAC 
Figure 9. Effects of the treatment with SAC on mitochondrial membrane potential on SJ-N-KP and IMR5 cells. The neuroblastoma cells, SJ-N-KP and 
IMR5, were incubated with increasing concentrations (0, 30 and 50 mM) of SAC for 48 h at 37˚C. Subsequently, mitochondrial membrane depolarization was 
assayed using JC‑1 and was examined by flow cytometry. The ratio of red (JC‑1 aggregate)/green (JC‑1 monomer) fluorescence intensity was used to represent 
the mitochondrial membrane potential. Results represent the mean values ± SD from 3 independent experiments. Data were analyzed by one‑way ANOVA, 
followed by Dunnett's post hoc test. *P<0.05 vs. control SJ-N-KP or IMR5 cells. SAC, S-allyl-L-cysteine. 
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induce the apoptosis of cancer cells by altering mitochondrial 
permeability transition and that the mitochondria may become 
a promising target for the treatment of malignancies.
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